Tangible Boost is a monthly treatment that restores the coating and maintains the wettability of Tangible’s proprietary rigid gas-permeable contact lenses.
Tangible Boost Receives FDA Clearance

Tangible Boost is a monthly treatment that restores the coating and maintains the wettability of Tangible’s proprietary rigid gas-permeable contact lenses.
ConsejoSano, recently selected for the Rosenman ADAPT program, raised $17 million in series B funding. The startup’s focus is to better communicate with patients based on their cultural background.
Kenota provides allergy specialists with a new approach to allergy testing, which takes less than 30 minutes and requires just a few drops of blood from a quick finger prick.
StimSite provides ob/gyns, general and colorectal surgeons the new ability to use their existing surgical instruments to help locate and identify ureters using electrical stimulation.
Study to Enroll 600 Patients and Evaluate Real-World Clinical and Patient Reported Outcomes Across All Brain Tumor Types
– First Patient Enrolled by Vidant Health in Greenville, N.C.
Seven Startups Selected from Global Field, Matched with Three Leading U.S. Healthcare Payers for Support and Funding
The funding will advance R&D on the JAZBI™ bioresorbable implant system. The award also provides access to the NSW healthcare system resources and critical insights from NSW Health medical devices expert panel.
Cala Health announced that it had received FDA breakthrough device designation for its Cala Trio treatment for action tremors in people with Parkinson’s disease.
Inc.’s third annual Female Founders 100 celebrates the success stories and best business advice of the game-changing women of 2020.
Alessa’s Biolen implant is designed to deliver an anti-androgen drug to the target tissue in the prostate.